Literature DB >> 6244386

Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart.

A Hedberg, K P Minneman, P B Molinoff.   

Abstract

The concentrations of beta-1 and beta-2 adrenergic receptors were determined in membranes prepared from the left ventricles and right atria of cat and guinea-pig hearts. The relative densities of the two receptor subtypes were determined by analyzing the kinetics of inhibition of specific [125I]iodohydroxybenzylpindolol binding by drugs previously found to show in vitro selectivity for beta-1 or beta-2 receptors. The right atria (including the sinoatrial node) from hearts of both species contained both beta-1 and beta-2 adrenergic receptors. Although beta-1 receptors predominated, approximately one-quarter of the beta adrenergic receptors in the atria were of the beta-2 subtype. The ventricles contained essentially only beta-1 adrenergic receptors. The densities of beta-1 and beta-2 adrenergic receptors were similar in the atria from both species. The cat left ventricle, however, contained twice as many receptors of the beta-1 type than did the ventricle of the guinea-pig heart. These results may explain previous findings that beta-2 selective drugs have more of an effect on chronotropy than on inotropy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244386

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  42 in total

Review 1.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

2.  Electrophysiological effects mediated by the stimulation of cardiac beta 2-adrenoceptors with tulobuterol.

Authors:  A Mugelli; S Amerini; P De Bonfioli Cavalcabo; E Cerbai; S Visentin
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

3.  Binding of beta 1-adrenoceptor antagonist [3H]CGP 26505 in rat cerebral cortex and sinus atrial node.

Authors:  G Chiellini; G Giannaccini; C Martini; A Lucacchini
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

Review 4.  Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.

Authors:  D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

5.  Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.

Authors:  E N Juberg; K P Minneman; P W Abel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

Review 6.  Pindolol--the pharmacology of a partial agonist.

Authors:  B J Clark; K Menninger; A Bertholet
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

7.  Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.

Authors:  A Hedberg; E Carlsson; E Fellenius; B Lundgren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

8.  (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.

Authors:  G Engel; D Hoyer; R Berthold; H Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

9.  Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.

Authors:  H Yabana; H Watanabe; H Narita; T Nagao
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

10.  Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat.

Authors:  A K Bahl; N M Clayton; J Coates; D P Martin; I G Oakley; P Strong; M A Trevethick
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.